EXHIBIT 8

Dr. Reddy’s Laboratories Limited

Dr. Reddy’s Laboratories Limited is the parent company. Tabulated below is the list of subsidiaries, joint ventures and associates as of March 31, 2025:

Name of the subsidiaries/associates/joint ventures	Country of Incorporation	Percentage of Direct/Indirect Ownership Interest
Aurigene Discovery Technologies (Malaysia) Sdn. Bhd.	Malaysia	100%⁽¹⁾
Aurigene Oncology Limited (formerly, Aurigene Discovery Technologies Limited)	India	100%
Aurigene Pharmaceutical Services Limited	India	100%⁽¹⁾
beta Institute gemeinnützige GmbH	Germany	100%⁽⁶⁾
betapharm Arzneimittel GmbH	Germany	100%⁽⁶⁾
Cheminor Employees Welfare Trust	India	Refer to below footnote⁽¹²⁾
Cheminor Investments Limited	India	100%
Chirotech Technology Limited (dissolved on September 18, 2024).	United Kingdom	100%
Clean Renewable Energy KK 2A Private Limited (from July 31, 2024)	India	26.99%⁽¹⁰⁾
Dr. Reddy’s (Beijing) Pharmaceutical Co. Limited	China	100%⁽⁷⁾
Dr. Reddy’s and Nestlé Health Science Limited (formerly, Dr. Reddy’s Nutraceuticals Limited) (refer note 36.A for details)	India	51%⁽¹⁵⁾
Dr. Reddy’s Bio-Sciences Limited	India	100%
Dr. Reddy’s Employees ESOS Trust	India	Refer to below footnote⁽¹²⁾
Dr. Reddy’s Farmaceutica Do Brasil Ltda.	Brazil	100%
Dr. Reddy’s Finland Oy (from December 20, 2024)	Finland	100%⁽⁷⁾
Dr. Reddy’s Formulations Limited	India	100%
Dr. Reddy’s Laboratories (Australia) Pty. Limited	Australia	100%⁽⁷⁾
Dr. Reddy’s Laboratories (EU) Limited	United Kingdom	100%⁽⁷⁾
Dr. Reddy’s Laboratories (Proprietary) Limited	South Africa	100%⁽⁷⁾
Dr. Reddy’s Laboratories (Thailand) Limited	Thailand	100%⁽⁷⁾
Dr. Reddy’s Laboratories (UK) Limited	United Kingdom	100%⁽³⁾
Dr. Reddy’s Laboratories Canada, Inc.	Canada	100%⁽⁷⁾
Dr. Reddy’s Laboratories Chile SPA.	Chile	100%⁽⁷⁾
Dr. Reddy’s Laboratories Inc.	U.S.A.	100%⁽⁷⁾
Dr. Reddy’s Laboratories Jamaica Limited (from September 25,2023)	Jamaica	100%⁽⁷⁾
Dr. Reddy’s Laboratories Japan KK	Japan	100%⁽⁷⁾
Dr. Reddy’s Laboratories Kazakhstan LLP	Kazakhstan	100%⁽⁷⁾
Dr. Reddy’s Laboratories LLC	Russia	100%⁽⁷⁾
Dr. Reddy’s Laboratories LLC, Ukraine	Ukraine	100%⁽⁷⁾
Dr. Reddy’s Laboratories Louisiana LLC (divested on March 21, 2025)	U.S.A.	100%⁽⁴⁾
Dr. Reddy’s Laboratories Malaysia Sdn. Bhd.	Malaysia	100%⁽⁷⁾
Dr. Reddy’s Laboratories New York, LLC	U.S.A.	100%⁽⁴⁾
Dr. Reddy’s Laboratories Philippines Inc.	Philippines	100%⁽⁷⁾
Dr. Reddy’s Laboratories Romania Srl	Romania	100%⁽⁷⁾
Dr. Reddy’s Laboratories SA	Switzerland	100%
Dr. Reddy’s Laboratories SAS	Colombia	100%⁽⁷⁾
Dr. Reddy’s Laboratories Taiwan Limited	Taiwan	100%⁽⁷⁾
Dr. Reddy’s New Zealand Limited.	New Zealand	100%⁽⁷⁾
Dr. Reddy’s Research Foundation	India	Refer to below footnote⁽¹²⁾
Dr. Reddy’s Srl	Italy	100%⁽⁸⁾
Dr. Reddy’s Venezuela, C.A. (dissolved on June 5, 2024)	Venezuela	100%
Dr. Reddy's Denmark ApS (from October 4, 2024)	Denmark	100%⁽⁷⁾
Dr. Reddy's Netherlands B.V. (formerly Dr.Reddy’s Research and Development B.V.)	Netherlands	100%⁽⁹⁾
DRES Energy Private Limited	India	26%⁽¹⁰⁾
DRL Impex Limited	India	100%⁽¹¹⁾
Idea2Enterprises (India) Pvt. Limited	India	100%
Imperial Owners and Land Possessions Private Limited (Formerly, Imperial Credit Private Limited) (entity under liquidation)	India	100%
Industrias Quimicas Falcon de Mexico, S.A. de CV	Mexico	100%
Kunshan Rotam Reddy Medicine Company Limited	China	51.33%^(2)(10)(14)
Kunshan Rotam Reddy Pharmaceutical Co. Limited	China	51.33%^(2)(10)
Lacock Holdings Limited	Cyprus	100%⁽⁷⁾
Nimbus Health GmbH	Germany	100%⁽⁶⁾
North Star OpCo Limited (from September 30, 2024)	United Kingdom	100%⁽¹³⁾
North Star Sweden AB (from September 30, 2024)	Sweden	100%⁽¹³⁾
Northstar Switzerland SARL (from September 30, 2024)	Switzerland	100%⁽⁷⁾
O2 Renewable Energy IX Private Limited	India	26%⁽¹⁰⁾
Promius Pharma LLC	U.S.A.	100%⁽⁴⁾
Reddy Holding GmbH	Germany	100%⁽⁷⁾
Reddy Netherlands B.V.	Netherlands	100%⁽⁷⁾
Reddy Pharma Iberia SAU	Spain	100%⁽⁷⁾
Reddy Pharma Italia S.R.L.	Italy	100%⁽⁵⁾
Reddy Pharma SAS	France	100%⁽⁷⁾
Svaas Wellness Limited	India	100%

⁽¹⁾

Indirectly owned through Aurigene Oncology Limited (Formerly, Aurigene Discovery Technologies Limited).

⁽²⁾

Kunshan Rotam Reddy Pharmaceutical Co. Limited and Kunshan Rotam Reddy Medicine Company Limited are subsidiaries as per Indian Companies Act, 2013, as the Company holds a 51.33% stake. However, the Company accounts for this investment by the equity method and does not consolidate it in the Company’s financial statements.

⁽³⁾

Indirectly owned through Dr. Reddy’s Laboratories (EU) Limited.

⁽⁴⁾

Indirectly owned through Dr. Reddy’s Laboratories Inc.

⁽⁵⁾

Indirectly owned through Lacock Holdings Limited.

⁽⁶⁾

Indirectly owned through Reddy Holding GmbH.

⁽⁷⁾

Indirectly owned through Dr. Reddy’s Laboratories SA.

⁽⁸⁾

Indirectly owned through Reddy Pharma Italia S.R.L.

⁽⁹⁾

Indirectly owned through Reddy Netherlands B.V.

⁽¹⁰⁾

Accounted using equity method as per IAS 28, “Investment in Associates and Joint Ventures”.

⁽¹¹⁾

Indirectly owned through Idea2Enterprises (India) Pvt. Limited.

⁽¹²⁾

The Company does not have any equity interests in this entity but has significant influence or control over it.

⁽¹³⁾

Indirectly owned through North Star Switzerland SARL.

⁽¹⁴⁾

Indirectly owned through Kunshan Rotam Reddy Pharmaceutical Co. Limited.